Alyeska Investment Group
ROIVW

Alyeska Investment Group’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Alyeska Investment Group’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-325,992
Closed -$625K – 572
2022
Q4 		$625K Buy
+325,992
New +$357K 0.01% 365

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
SOA
Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Alyeska Investment Group's ROIVW Position: Q1 2023 in Review

Alyeska Investment Group sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q1 2023, closing a stake of 325,992 shares — an estimated $625K sold.

Alyeska Investment Group first reported a position in ROIVW in Q4 2022 and held it in 1 quarter. The position peaked at $625K in Q4 2022. 23 funds tracked by Wall St. Rank hold ROIVW as of Q1 2023.

  • Alyeska Investment Group reported no remaining Roivant Sciences Ltd. Warrant position as of Q1 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 325,992 Roivant Sciences Ltd. Warrant shares in Q1 2023, an estimated $625K.
  • Alyeska Investment Group first reported a position in Roivant Sciences Ltd. Warrant in Q4 2022 and held it in 1 quarter.
  • Alyeska Investment Group's Roivant Sciences Ltd. Warrant position peaked at $625K in Q4 2022.
  • 23 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q1 2023.

Based on Alyeska Investment Group's 13F filing for Q1 2023, filed 15 May 2023.